Correlation Between Medesis Pharma and Implanet

Can any of the company-specific risk be diversified away by investing in both Medesis Pharma and Implanet at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medesis Pharma and Implanet into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medesis Pharma SA and Implanet SA, you can compare the effects of market volatilities on Medesis Pharma and Implanet and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medesis Pharma with a short position of Implanet. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medesis Pharma and Implanet.

Diversification Opportunities for Medesis Pharma and Implanet

-0.48

Correlation Coefficient

Medesis Pharma  Implanet

Very good diversification

The 3 months correlation between Medesis and Implanet is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Medesis Pharma SA and Implanet SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Implanet SA and Medesis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medesis Pharma SA are associated (or correlated) with Implanet. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Implanet SA has no effect on the direction of Medesis Pharma i.e., Medesis Pharma and Implanet go up and down completely randomly.

Pair Corralation between Medesis Pharma and Implanet

Assuming the 90 days trading horizon Medesis Pharma SA is expected to under-perform the Implanet. In addition to that, Medesis Pharma is 1.2 times more volatile than Implanet SA. It trades about -0.07 of its total potential returns per unit of risk. Implanet SA is currently generating about 0.02 per unit of volatility. If you would invest  11.00  in Implanet SA on September 13, 2024 and sell it today you would earn a total of  0.00  from holding Implanet SA or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Medesis Pharma SA  vs.  Implanet SA

Medesis Pharma SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medesis Pharma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Implanet SA

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Implanet SA are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Implanet may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Medesis Pharma and Implanet

The main advantage of trading using opposite Medesis Pharma and Implanet positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medesis Pharma position performs unexpectedly, Implanet can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Implanet will offset losses from the drop in Implanet's long position.

The idea behind Medesis Pharma SA and Implanet SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.